# Cradle vs Unlearn.AI

Cradle records 16,993 monthly visits with -22.3% month-over-month growth and Contact for Pricing pricing. Unlearn.AI records 17,107 monthly visits with -32.5% growth and Contact for Pricing pricing.

| Metric | [Cradle](https://openaitools.app/tool/cradle) | [Unlearn.AI](https://openaitools.app/tool/unlearn-ai) |
| :--- | :--- | :--- |
| Website URL | https://cradle.bio | https://unlearn.ai |
| Categories | AI Design Generator, AI Healthcare, AI Research Tool, AI Productivity Tools | AI Healthcare, AI Research Tool, AI Predictions, AI Models |
| Pricing Model | Contact for Pricing | Contact for Pricing |
| Monthly Visits | 16,993 | 17,107 |
| MoM Growth Rate | -22.3% | -32.5% |
| Primary Market | Netherlands | United States |
| Direct Visits | 6,214 | 7,493 |
| Review Score | 4.5 | 4.4 |
| Saved Count | 2 | 1 |
| Supported Platforms | Website | Website |

## Cradle

Cradle is a protein engineering platform that applies machine learning to the design and optimization of proteins. Instead of optimizing one property at a time, teams use Cradle to work on potency, specificity, expression, thermostability, and manufacturability simultaneously — compressing the number of experimental rounds needed to reach a candidate that meets a target profile.

The platform covers a broad range of protein classes, including antibodies for ADC and multispecific formats, enzymes that need to hold up in hostile conditions, vaccine antigens that must keep their shape outside the lab, and peptides that need potency within tight constraints even from small datasets. It works whether or not a starting protein already exists, and it learns from the customer's own experimental data, including results from previous failed campaigns, so each design round is better informed than the last.

Cradle is positioned for multiple roles in an organization: experimental scientists get point-and-click candidate design and optimization; computational scientists get the same functionality exposed through an API for scripting and integration; and R&D leadership gains a compounding advantage from every experiment their teams have run. Security is a stated priority, with ISO 27001 and SOC 2 Type II certification and hosting on Google Cloud. Pricing is not published — interested teams discuss their project with Cradle to get terms.

**Pricing & Plans:** Pricing is not publicly listed. Cradle uses a contact-for-pricing model where teams discuss their project and program scope directly with the company; a licensing track and API access are offered alongside the core platform.

- **De novo protein design:** Start from a target or your own sequence and have Cradle design an optimized plate of candidates informed by your data and domain knowledge.
- **Parallel multi-property optimization:** Improve efficacy, developability, and manufacturability in parallel rather than one property at a time, compressing time to a target profile.
- **Closed-loop learning from experimental data:** Every round incorporates results from the previous one, so experimental data compounds across campaigns and prior failed programs stay useful.
- **Full API access:** Everything in the web application is exposed through the API, so computational teams can script campaigns and wire Cradle into existing pipelines.
- **Enterprise-grade security and compliance:** ISO 27001 and SOC 2 Type II certified, hosted on Google Cloud with data isolation and continuous monitoring for enterprise deployments.

**Strengths:** Optimizes multiple protein properties in parallel rather than sequentially, which can cut the number of experimental rounds; Learns from a customer's own experimental data, including negative and failed results; Covers antibodies, enzymes, vaccines, and peptides in one platform; Full API parity with the web app supports computational and automated workflows

**Limitations:** No self-serve trial or published pricing, so evaluation requires a sales conversation; Requires in-house experimental capability to generate the assay data that drives the models; Cost and onboarding are geared to organizations rather than individual researchers

[Profile (Markdown)](https://openaitools.app/tool/cradle.md)

## Unlearn.AI

Unlearn.AI works with biopharma sponsors and clinical research teams at three points in a trial's lifecycle: before the protocol is finalized, while the study is running, and after readout. In design, teams model the patients they expect to enroll and pressure-test sample size, eligibility criteria, endpoints, and comparators before locking the protocol. The company's PROCOVA method — described as EMA-qualified and FDA-supported — applies twin-based covariate adjustment to reduce sample size in randomized controlled trials while holding statistical power, or to increase power without adding patients.

Mid-study, Unlearn supports pre-specified twin-based analyses that tighten interim estimates without enrolling anyone new, and lets teams re-run design scenarios when new evidence — a competitor readout, a fresh publication, or blinded data drifting from assumptions — changes the picture. After a study reads out, digital twins are used to contextualize population, endpoints, and variability, improving sensitivity across endpoints and helping teams re-evaluate historical trial data with regulatory-aligned methods.

Unlearn publishes concrete case outcomes: a 20% sample-size reduction built into a Phase 1/2 design with roughly $2M in savings, a 33% smaller control arm and four-plus months of enrollment time saved in a re-analysis of completed Phase 3 trials from a top-5 global sponsor, and a completed Phase 3 ALS trial re-analyzed to keep full power with 92 fewer participants. The company partners with sponsors including Trace Neuroscience, QurAlis, Acumen Pharmaceuticals, SOLA Biosciences, VectorY Therapeutics, and CHDI Foundation, and states it works with top global pharma companies. Unlearn does not publish list pricing; engagements are scoped through direct contact.

**Pricing & Plans:** Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

- **AI-generated patient digital twins:** Model-based forecasts of each participant's clinical outcomes, generated from baseline data already collected, that act as a virtual comparator or as additional information per enrolled patient.
- **PROCOVA design and analysis method:** A twin-based covariate adjustment approach that Unlearn describes as EMA-qualified and FDA-supported, used to reduce sample size in randomized controlled trials while maintaining power.
- **Trial design scenario modeling:** Build and compare design scenarios — endpoints, eligibility criteria, sample size, assumptions — so governance decisions are made with quantified tradeoffs instead of positions.
- **Interim and readout analysis support:** Pre-specified twin-based analyses added to the statistical analysis plan before unblinding, plus twin-adjusted analysis delivered at interim and at readout.
- **Externally controlled study design:** Design single-arm and externally controlled studies where randomization is not an option, selecting eligibility criteria that give open-label studies the best chance of a clear readout.

**Strengths:** Digital twins are generated from data already collected, so no extra patients are required to gain information; Publicly reported, quantified outcomes — sample-size reductions, cost savings, and enrollment time saved — rather than only qualitative claims; Covers the whole trial lifecycle: design, interim, and readout, not just one decision point; Named collaborations with biotech and pharma sponsors, plus regulatory-aligned methodology

**Limitations:** Pricing is not published, so budgeting requires a direct sales conversation; The value proposition depends on regulatory acceptance of twin-based methods, which varies by agency and indication; Best suited to sponsors with existing clinical data and statistical teams; not a self-serve tool; Public metrics come from specific studies and may not transfer directly to other indications

[Profile (Markdown)](https://openaitools.app/tool/unlearn-ai.md)

## Frequently Asked Questions

### How do Cradle and Unlearn.AI compare in monthly traffic?

Cradle has 16,993 monthly visits, while Unlearn.AI has 17,107. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Cradle has a month-over-month growth rate of -22.3%; Unlearn.AI has -32.5%.

### How does pricing compare?

Cradle: Contact for Pricing. Pricing is not publicly listed. Cradle uses a contact-for-pricing model where teams discuss their project and program scope directly with the company; a licensing track and API access are offered alongside the core platform. Unlearn.AI: Contact for Pricing. Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | 723,847 | -1.2% | Free Trial | Guideline-directed medical answers with citations, built for clinicians | [.md](https://openaitools.app/tool/dr-oracle.md) |
| 2 | [Upheal](https://openaitools.app/tool/upheal-io) | 347,782 | -2.1% | Freemium, Free Trial, Contact for Pricing | AI therapy notes and an AI-native EHR built for mental health professionals. | [.md](https://openaitools.app/tool/upheal-io.md) |
| 3 | [Uizard](https://openaitools.app/tool/uizard) | 294,618 | -15% | Freemium | AI-powered UI design and prototyping for product teams | [.md](https://openaitools.app/tool/uizard.md) |
| 4 | [Empirical Health](https://openaitools.app/tool/empirical-health) | 70,517 | -28.8% | Paid | Measure, predict and prevent heart disease with data | [.md](https://openaitools.app/tool/empirical-health.md) |
| 5 | [Quilter](https://openaitools.app/tool/quilter) | 49,305 | -15.7% | Freemium, Contact for Pricing | Physics-driven AI that automates PCB placement and routing | [.md](https://openaitools.app/tool/quilter.md) |
| 6 | [Delve AI](https://openaitools.app/tool/delve) | 49,025 | -4.6% | Freemium | Generate data-backed personas, digital twins and synthetic research on demand | [.md](https://openaitools.app/tool/delve.md) |
| 7 | [Oatmeal Health](https://openaitools.app/tool/oatmeal-health) | 40,264 | -44.9% | Contact for Pricing | AI lung cancer screening that finds eligible patients and scores every nodule | [.md](https://openaitools.app/tool/oatmeal-health.md) |
| 8 | [Database Sample](https://openaitools.app/tool/open-source-database-designs) | 35,340 | +69.1% | Freemium | Ready-made database schemas, sample data and an AI schema designer | [.md](https://openaitools.app/tool/open-source-database-designs.md) |
| 9 | [RapidAI](https://openaitools.app/tool/rapidai-com) | 20,172 | -27.9% | Contact for Pricing | Enterprise clinical AI that turns medical imaging into faster, more confident care decisions. | [.md](https://openaitools.app/tool/rapidai-com.md) |
| 10 | [January AI](https://openaitools.app/tool/january-ai) | 10,183 | +7.6% | Free, Contact for Pricing | Health intelligence infrastructure for nutrition and metabolic data | [.md](https://openaitools.app/tool/january-ai.md) |

---
Source: https://openaitools.app/compare/cradle-vs-unlearn-ai

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
